New registry to track Long-Term safety of experimental tongue dysphagia treatment
NCT ID NCT07429890
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is a long-term registry for people who received the experimental drug iltamiocel in a previous study for tongue swallowing problems caused by head and neck cancer treatment. The goal is to monitor safety and see if the drug continues to help with swallowing over time. About 31 participants will be followed for several years.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OROPHARYNGEAL DYSPHAGIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UC Davis Medical Center
Sacramento, California, 95817, United States
-
UC SanFrancisco Medical Center
San Francisco, California, 94115, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a botox shot in the throat restore swallowing after stroke or Parkinson's?
- Simple breathing trick may help cancer survivors swallow safely
- Can your own muscle cells fix swallowing? early trial begins
- Can a gentle zap under the chin help you swallow better?
- Suction catheter aims to stop food from going down the wrong pipe
- Neck-Worn swallow detector fails key test